Long
VAXX Biotech Penny Stock Earnings Play

VAXX is a speculative penny biotechnology NASDAQ stock with high volatility. On the 2H chart, it is currently trending up from a swing low
on April 25 with earnings to be reported Monday 5/8. May's relative volume compared with that of April is about 2-3X higher. To confirm
the bullish bias, VAXX is currently trading above its intermediate-term POC line on the volume profile. This confirms buyers as being in
control. Although this is speculative as are all biotechnology penny stocks, impending earnings as a catalyst has been considered.
Continued development in the vaccine subsector at large may suggest VAXX may have a favorable report to fuel further price action.
on April 25 with earnings to be reported Monday 5/8. May's relative volume compared with that of April is about 2-3X higher. To confirm
the bullish bias, VAXX is currently trading above its intermediate-term POC line on the volume profile. This confirms buyers as being in
control. Although this is speculative as are all biotechnology penny stocks, impending earnings as a catalyst has been considered.
Continued development in the vaccine subsector at large may suggest VAXX may have a favorable report to fuel further price action.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.